Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428943 · ClinicalTrials.gov registry record · Phase 1
OPT101 in Type 1 Diabetes Patients
A Phase 1 study, sponsored by Op-T.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT05428943 is a Phase 1 study that has completed, run by Op-T. The registered enrollment target is 22 participants.
The verdict
NCT05428943, a Phase 1 study, has completed, sponsored by Op-T.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
Phase 1b designed to assess safety, pharmacokinetics, immunological and clinical effects of multiple ascending doses of OPT101.
Interventions
- DRUG OPT101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2024-02-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05428943
The ClinicalTrials.gov registry entry for NCT05428943 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Op-T, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OPT101 is the first listed.
NCT05428943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05428943 about?
NCT05428943 is a clinical study titled "OPT101 in Type 1 Diabetes Patients". Phase 1b designed to assess safety, pharmacokinetics, immunological and clinical effects of multiple ascending doses of OPT101.
What is the current status of trial NCT05428943?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2022-09-27. Estimated completion is 2024-02-21.
What interventions are being tested in trial NCT05428943?
The interventions under investigation include: OPT101 (DRUG).
Who is sponsoring clinical trial NCT05428943?
This trial is sponsored by Op-T, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.